Ningbo Jiangnan Capsule Co., Ltd.

Ningbo Jiangnan Capsule Co., Ltd.

Pharma Capsule Trends Plant-Based Smart Eco Precise

2025 03/24

default name
1- Global Growth and Regional Differentiation
 
The global pharmaceutical capsule shell market is expanding steadily at a compound annual growth rate of 4%-6%, with the main driving forces including population aging, rising demand for chronic diseases and technological innovation. The regional pattern shows a clear differentiation:
 
(1) Asia-Pacific region: China and India have become growth engines, policy support (such as China's drug centralized procurement) and a large consumer group have driven market expansion, and demand is expected to exceed 638.94 billion tablets in 2025 (a year-on-year increase of 6.4%).
 
(2) European and American markets: Focusing on high-end fields, innovative dosage forms such as enteric-coated capsules and targeted preparations dominate, and there is strong demand for biotechnology and personalized medicine.
 
2- Technological innovation: plant-based and intelligent production double breakthrough
 
(1) Plant-based capsules explode
 
Growth data: In 2023, the sales of plant capsules increased by 1000% year-on-year, and the global market size is expected to reach US$1.585 billion in 2026 (CAGR 7.6%).
 
Advantages: Natural starch materials (such as cassava) replace traditional gelatin, the production process is pollution-free, and the pressure resistance is strong, which is suitable for sensitive people.
 
Case: Erkang Pharmaceutical Starch Plant Capsules have covered more than 20 countries and served more than 1,000 high-end nutrition brands.
 
(2) Intelligent production and quality control upgrade
 
AI visual inspection: 360° appearance inspection equipment (such as Navel hard capsule inspection machine) replaces manual sampling, with an efficiency improvement of 50% and a defect recognition rate of 99.9%.
 
3D printing technology: The intelligent intestinal targeted drug delivery system accurately controls the drug release position by printing multiple layers of drug coatings at low temperature to maintain the activity of "live drugs".
 
3- nvironmental protection and policy: industrial upgrading under dual constraints
 
(1) Environmental regulations are becoming stricter
 
Shanghai standards: The first "Guidelines for Reducing the Volume of Pharmaceutical Packaging" in China was implemented, limiting excessive packaging of capsules and promoting biodegradable materials.
 
EU/FDA requirements: prohibiting the use of phosphorus-containing materials and promoting the development of plant-based and biodegradable capsules.
 
(2) Quality supervision upgrade
 
GMP strengthening: cleanliness of the production environment, temperature and humidity control (such as 18-25℃, 45-65% humidity) become standard.
 
Intelligent monitoring: Aluminum foil sealing detection equipment uses infrared imaging to determine the sealing in real time, avoiding manual sampling omissions.
 
4- Future trends: Precision medicine and the rise of traditional Chinese medicine
 
(1) Personalized medicine
 
Targeted technology: 3D printed capsule shells achieve targeted release in the intestine, improve drug efficacy and reduce side effects.
 
Intelligent diagnosis: IoT technology enables capsule status tracking, and patient compliance is increased by 30%.
 
(2) Internationalization of Chinese medicine capsules
 
Policy dividends: The Implementation Plan for Major Projects for the Revitalization and Development of Traditional Chinese Medicine promotes the standardization of Chinese medicine capsules, and the market size is expected to exceed 500 billion yuan in 2024.
 
Technology upgrade: New gelatin materials improve solubility and stability, and leading companies such as Huangshan Capsules are accelerating their overseas expansion.
 
Conclusion
The pharmaceutical capsule shell market is undergoing a transformation from "basic packaging" to "technological carrier". The four major trends of plant-based materials, intelligent production, environmental compliance and precision medicine will reshape the industry's competitive landscape. Companies need to focus on technological innovation (such as 3D printing targeted drug delivery) and sustainable development (such as degradable materials) in order to gain an advantage in the global market.
default name